EMERGING COMPLIANCE CHALLENGES FOR 2027
As organisations move toward 2027, traditional compliance models built to manage identifiable risks – bribery, competition law, promotional compliance, data privacy, sanctions and financial controls – need to evolve. While these risks remain important, the nature of compliance risk is changing.
The emergence of generative artificial intelligence (genAI), increasing geopolitical fragmentation, evolving stakeholder expectations, greater environmental, social and governance (ESG) scrutiny, supply chain accountability requirements, heightened enforcement activity, and the growing regulatory focus on algorithmic decision making are creating a far more complex compliance environment. Compliance is no longer about adherence to rules. It is becoming a strategic capability that enables trust, resilience and responsible innovation.
The central challenge heading into 2027 is that regulatory developments are occurring faster than organisational governance structures can adapt. Organisations increasingly face situations where legal requirements are unclear, fragmented across jurisdictions or still emerging. In this environment, compliance leaders must shift from a model based on rule interpretation toward one focused on risk anticipation, ethical judgement, governance agility and continuous monitoring.
Historically, compliance evolved primarily as a control function. Its purpose was to ensure organisations complied with established laws and regulations. Success was often measured through audit findings, policy completion rates, training metrics and the absence of enforcement actions. As we move toward 2027, the compliance environment is changing. Regulators increasingly expect organisations to demonstrate not merely compliance with individual rules but evidence of effective governance systems, ethical decision-making processes and adequate risk oversight.
Regulators increasingly pose questions. Did the organisation identify foreseeable risks? Were safeguards proportionate? Was senior leadership sufficiently informed?
Oct-Dec 2026 Issue
GSK